Warning: The NCBI web site requires JavaScript to function. more...
Genetic polymorphisms in the cyclooxygenase-2 gene, use of nonsteroidal anti-inflammatory drugs, and breast cancer risk.
Shen J, Gammon MD, Terry MB, Teitelbaum SL, Neugut AI, Santella RM.
Breast Cancer Res. 2006;8(6):R71.
Related citations
Association between frequent use of nonsteroidal anti-inflammatory drugs and breast cancer.
Rahme E, Ghosn J, Dasgupta K, Rajan R, Hudson M.
BMC Cancer. 2005 Dec 12;5:159.
Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health-AARP Diet and Health Study.
Gierach GL, Lacey JV Jr, Schatzkin A, Leitzmann MF, Richesson D, Hollenbeck AR, Brinton LA.
Breast Cancer Res. 2008;10(2):R38. Epub 2008 Apr 30.
Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk.
Terry MB, Gammon MD, Zhang FF, Tawfik H, Teitelbaum SL, Britton JA, Subbaramaiah K, Dannenberg AJ, Neugut AI.
JAMA. 2004 May 26;291(20):2433-40.
IL6, aspirin, nonsteroidal anti-inflammatory drugs, and breast cancer risk in women living in the southwestern United States.
Slattery ML, Curtin K, Baumgartner R, Sweeney C, Byers T, Giuliano AR, Baumgartner KB, Wolff RR.
Cancer Epidemiol Biomarkers Prev. 2007 Apr;16(4):747-55.
Genetic variants in COX-2, non-steroidal anti-inflammatory drugs, and breast cancer risk: the Western New York Exposures and Breast Cancer (WEB) Study.
Brasky TM, Bonner MR, Moysich KB, Ochs-Balcom HM, Marian C, Ambrosone CB, Nie J, Tao MH, Edge SB, Trevisan M, Shields PG, Freudenheim JL.
Breast Cancer Res Treat. 2011 Feb;126(1):157-65. Epub 2010 Jul 30.
Nonsteroidal antiinflammatory drugs, cyclooxygenase polymorphisms, and the risk of developing breast carcinoma among women with benign breast disease.
Gallicchio L, McSorley MA, Newschaffer CJ, Thuita LW, Huang HY, Hoffman SC, Helzlsouer KJ.
Cancer. 2006 Apr 1;106(7):1443-52.
Aspirin, NSAIDs, and colorectal cancer: possible involvement in an insulin-related pathway.
Slattery ML, Samowitz W, Hoffman M, Ma KN, Levin TR, Neuhausen S.
Cancer Epidemiol Biomarkers Prev. 2004 Apr;13(4):538-45.
COX-2 polymorphism, use of nonsteroidal anti-inflammatory drugs, and risk of colon cancer in African Americans (United States).
Sansbury LB, Millikan RC, Schroeder JC, North KE, Moorman PG, Keku TO, de Cotret AR, Player J, Sandler RS.
Cancer Causes Control. 2006 Apr;17(3):257-66.
Association of aspirin and nonsteroidal anti-inflammatory drug use with breast cancer.
Johnson TW, Anderson KE, Lazovich D, Folsom AR.
Cancer Epidemiol Biomarkers Prev. 2002 Dec;11(12):1586-91.
Protective effect of NSAIDs on cancer and influence of COX-2 C(-765G) genotype.
Siemes C, Visser LE, Coebergh JW, Hofman A, Uitterlinden AG, Stricker BH.
Curr Cancer Drug Targets. 2008 Dec;8(8):753-64.
The role of cytokine gene polymorphisms in colorectal cancer and their interaction with aspirin use in the northeast of Scotland.
Macarthur M, Sharp L, Hold GL, Little J, El-Omar EM.
Cancer Epidemiol Biomarkers Prev. 2005 Jul;14(7):1613-8.
Prescriptions for selective cyclooxygenase-2 inhibitors, non-selective non-steroidal anti-inflammatory drugs, and risk of breast cancer in a population-based case-control study.
Cronin-Fenton DP, Pedersen L, Lash TL, Friis S, Baron JA, Sørensen HT.
Breast Cancer Res. 2010;12(2):R15. Epub 2010 Mar 1.
PTGS2 (COX-2) -765G > C promoter variant reduces risk of colorectal adenoma among nonusers of nonsteroidal anti-inflammatory drugs.
Ulrich CM, Whitton J, Yu JH, Sibert J, Sparks R, Potter JD, Bigler J.
Cancer Epidemiol Biomarkers Prev. 2005 Mar;14(3):616-9. Erratum in: Cancer Epidemiol Biomarkers Prev. 2005 Dec;14(12):3020.
Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitors.
Harris RE, Beebe-Donk J, Alshafie GA.
BMC Cancer. 2006 Jan 30;6:27.
Use of nonsteroidal antiinflammatory drugs and risk of breast cancer: the Case-Control Surveillance Study revisited.
Zhang Y, Coogan PF, Palmer JR, Strom BL, Rosenberg L.
Am J Epidemiol. 2005 Jul 15;162(2):165-70. Epub 2005 Jun 22.
Genetic polymorphisms in TP53, nonsteroidal anti-inflammatory drugs and the risk of colorectal cancer: evidence for gene-environment interaction?
Tan XL, Nieters A, Hoffmeister M, Beckmann L, Brenner H, Chang-Claude J.
Pharmacogenet Genomics. 2007 Aug;17(8):639-45.
Nonsteroidal anti-inflammatory drug use and breast cancer risk: a Danish cohort study.
Friis S, Thomassen L, Sørensen HT, Tjønneland A, Overvad K, Cronin-Fenton DP, Vogel U, McLaughlin JK, Blot WJ, Olsen JH.
Eur J Cancer Prev. 2008 Apr;17(2):88-96.
Aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs in cancer prevention: a critical review of non-selective COX-2 blockade (review).
Harris RE, Beebe-Donk J, Doss H, Burr Doss D.
Oncol Rep. 2005 Apr;13(4):559-83. Review.
Aspirin and other nonsteroidal anti-inflammatory drugs and breast cancer incidence in a large U.S. cohort.
Jacobs EJ, Thun MJ, Connell CJ, Rodriguez C, Henley SJ, Feigelson HS, Patel AV, Flanders WD, Calle EE.
Cancer Epidemiol Biomarkers Prev. 2005 Jan;14(1):261-4.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on